Original Articles

by Author NameMay 23, 2022

Original Articles

2021
94 Hayashi N, Yamasaki A, Ueda S, Okazaki S, Ohno Y, Tanaka T, Endo Y, Tomioka Y, Masuko
K, Masuko T, Sugiura R. Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target. Oncotarget, 12:1256-1270, 2021. (PubMed)

2020                                                                
93 Manabe E, Ito S, Ohno Y, Tanaka T, Naito Y, Sasaki N, Asakura M, Masuyama T, Ishihara M, Tsujino T. Reduced lifespan of erythrocytes in Dahl/Salt sensitive rats is the cause of the renal proximal tubule damage. Sci Rep, 10:22023, 2020. (PubMed)

2019                                                 92  Ito S, Ohno Y, Tanaka T, Kobuchi S, Ayajiki K, Manabe E, Masuyama T, Jun-ichi S, Tsujino T. Neutrophil/lymphocyte ratio elevation in renal dysfunction is caused by distortion of leukocyte hematopoiesis in bone marrow. Ren Fail, 41:284-293, 2019. (PubMed)

2018
91 Ohno Y, Shingyoku S, Miyake S, Tanaka A, Fudesaka S, Shimizu Y, Yoshifuji A, Yamawaki Y, Yoshida S, Tanaka S, Sakura K, Tanaka T. Differential Regulation of the Sphere Formation and Maintenance of Cancer-Initiating Cells of Malignant Mesothelioma via CD44 and ALK4 Signaling Pathways. Oncogene, 37:6357-6367, 2018. (PubMed)

90 Hara Y, Torii, R, Ueda S, Kurimoto E, Ueda Eri, Okura H, Tatano Yutaka, Yagi H, Ohno Y, Tanaka T, Masuko K, Masuko T. Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1. Cancer Science, 109:3171-3182, 2018.
(PubMed)

2015
89 Man CH, Wan H, Cher CY, Fan A, Fung TK, Wan TS, Tanaka T, So CW, Kwong YL, Leung AY. Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia. Blood, 125:3928-3936, 2015. (PubMed)

2013
88 Umemoto E, Takeda A, Jin S, Luo Z, Nakahogi N, Hayasaka H, Lee CM, Tanaka T, Miyasaka M. Dynamic changes in endothelial cell adhesion molecule nepmucin/CD300LG expression under physiological and pathological conditions. PLOS One, 8:e83681, 2013.  (PubMed)

87  Bai Z, Cai L, Umemoto E, Takeda A, Tohya K, Komai Y, Veeraveedu PT, Hata H, Sugiura Y, Kubo A, Suematsu M, Hayasaka H, Okudaira S, Aoki J, Tanaka T, Albers HMHG, Ovaa H, Miyasaka M. Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the Autotaxin/Lysophosphatidic Acid axis. J Immunol, 190:2036-2048, 2013. (PubMed)

2012
86 Sekiguchi S, Kimura K, Chiyo T, Ohtsuki T, Tobita Y, Tokunaga Y, Yasui F, Tsukiyama-Kohara K, Wakita T, Tanaka T, Miyasaka M, Mizuno K, Hayashi Y, Hishima T, Matsushima K, Kohara M. Immunization with a recombinant vaccinia virus that encodes nonstructural proteins of the hepatitis C virus suppresses viral protein levels in mouse liver. PLoS One, 7:e51656, 2012. (PubMed)

85  Bobbala D, Chen XL, Leblanc C, Mayhue M, Stankova J, Tanaka T, Chen YG, Ilangumaran S, Ramanathan S. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. Diabetologia, 55:3010-3020, 2012. (PubMed)

84  Hara K, Ueda S, Ohno Y, Tanaka T, Yagi H, Okazaki S, Kawahara R, Masayuki T, Enomoto T, Hashimoto Y, Masuko K, Masuko T. NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation. Cancer Sci, 103:1460-1466, 2012. (PubMed)

83  Umemoto E, Otani K, Ikeno T, Verjan Garcia N, Hayasaka H, Bai Z, Jang MH, Tanaka T, Nagasawa T, Ueda K, Miyasaka M. Constitutive plasmacytoid dendritic cell migration to the splenic white pulp is cooperatively regulated by CCR7- and CXCR4-mediated signaling. J Immunol, 189:191-199, 2012. (PubMed)

2011
82  Ohkawa M, Ohno Y, Masuko K, Takeuchi A, Suda K, Kubo A, Kawahara R, Okazaki S, Tanaka T, Saya H, Seki M, Enomoto T, Yagi H, Hashimoto Y, Masuko T. Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy. Biochem Biophys Res Commun, 406:649-655, 2011. (PubMed)

2010
81  Kikushige Y, Shima T, Takayanagi S, Urata S, Miyamoto T, Iwasaki H, Takenaka K, Teshima T, Tanaka T, Inagaki Y, Akashi K. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells. Cell Stem Cell, 7:708-717, 2010. (PubMed)

80  Satoh K, Takahashi H, Matsuda C, Tanaka T, Miyasaka M, Zeniya M, Kohara M. Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice. J Med Virol, 82:1545-1553, 2010. (PubMed)

79  Tanaka T, Moriwaki K, Murata S, Miyasaka M. LIM domain-containing adaptor, leupaxin, localizes in focal adhesion and suppresses the integrin-induced tyrosine phosphorylation of paxillin. Cancer Sci, 101: 363-368, 2010. (PubMed)

78  Li W, Kubo S, Okuda A, Yamamoto H, Ueda H, Tanaka T, Nakamura H, Yamanishi H, Terada N, Okamura H. Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2. J Immunother, 33:287-296, 2010. (PubMed)

77  Ebisuno Y, Katagiri K, Katakai T, Ueda Y, Nemoto T, Inada H, Nabekura J, Okada T, Kannagi R, Tanaka T, Miyasaka M, Hogg N, Kinashi T. Rap1 controls lymphocyte adhesion cascade and interstitial migration within lymph nodes in RAPL-dependent and -independent manners. Blood, 115:804-814, 2010. (PubMed)

2009
76  Yokoyama S, Watanabe N, Sato N, Perera PY, Filkoski L, Tanaka T, Miyasaka M, Waldmann TA, Hiroi T, Perera LP. Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes. Proc Natl Acad Sci U S A, 106, 15849-15854, 2009. (PubMed)

2008
75  *Nakasaki T, *Tanaka T, Okudaira S, Hirosawa M, Umemoto E, Otani K, Jin S, Bai Z, Hayasaka H, Fukui Y, Aozasa K, Fujita N, Tsuruo T, Ozono K, Aoki J, Miyasaka M. (*equal contribution) Involvement of a lysophosphatidic-acid generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am J Pathol, 173:1566-1576, 2008. (PubMed)

74  Minamimura K, Sato K, Yagita H, Tanaka T, Arii S, Maki T. Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice. Am J Transplant, 8:761-772, 2008. (PubMed)

73  Jin S, Umemoto E, Tanaka T, Shimomura Y, Tohya K, Kunizawa K, Yang BG, Jang MH, Hirata T, Miyasaka M. Nepmucin/CLM-9, an Ig domain-containing sialomucin in vascular endothelial cells, promotes lymphocyte transendothelial migration in vitro. FEBS Lett, 582:3018-3024, 2008. (PubMed)

72  Sugahara KN, Hirata T, Tanaka T, Ogino S, Takeda M, Terasawa H, Shimada I, Tamura J, ten Dam GB, van Kuppevelt TH, Miyasaka M. Chondroitin sulfate E fragments enhance CD44 cleavage and CD44-dependent motility in tumor cells. Cancer Res, 68:7191-7199, 2008. (PubMed)

71  Thompson LF, Takedachi M, Ebisuno Y, Tanaka T, Miyasaka M, Mills JH, Bynoe MS. Regulation of leukocyte migration across endothelial barriers by ecto-5'-nucleotidase-generated adenosine. Nucleosides Nucleotides Nucleic Acids, 27:755-760, 2008. (PubMed)

70  Takedachi M, Qu D, Ebisuno Y, Oohara H, Joachims ML, McGee ST, Maeda E, McEver RP, Tanaka T, Miyasaka M, Murakami S, Krahn T, Blackburn MR, Thompson LF. CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. J Immunol, 180:6288-6296, 2008. (PubMed)

69  Bai Z, Hayasaka H, Nishiyama M, Tanaka T, Jang MH, Umemoto E, Miyasaka M. Heterogeneity of in vitro lymphocyte behaviours in response to different chemokines. Med J Osaka Univ, 51:11-20, 2008.

2007
68  Yang BG, Tanaka T, Jang MH, Bai Z, Hayasaka H, Miyasaka M. Binding of lymphoid chemokines to collagen IV that accumulates in the basal lamina of high endothelial venules; its implication in lymphocyte trafficking. J Immunol, 179:4376-4382, 2007. (PubMed)

67 *Matsutani T, *Tanaka T, Tohya K, Otani K, Jang MH, Umemoto E, Taniguchi K, Hayasaka H, Ueda K, Miyasaka M. (*equal contribution) Plasmacytoid dendritic cells employ multiple cell adhesion molecules sequentially to interact with high endothelial venule cells - Molecular basis of their trafficking to lymph nodes. Int Immunol, 19:1031-1037, 2007. (PubMed)

66 Matsumoto M, Shigeta A, Furukawa Y, Tanaka T, Miyasaka M, Hirata T. CD43 collaborates with P-selectin glycoprotein ligand-1 to mediate E-selectin-dependent T cell migration into inflamed skin. J Immunol, 178:2499-2506, 2007. (PubMed)

65 Yotsui T, Yasuda O, Kawamoto H, Higuchi M, Chihara Y, Umemoto E, Tanaka T, Miyasaka M, Rakugi H, Ogihara T. Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cells. FEBS Lett, 581:427-432, 2007. (PubMed)

2006
64 Watanabe T, Masuyama J, Sohma Y, Inazawa H, Horie K, Kojima K, Uemura Y, Aoki Y, Kaga S, Minota S, Tanaka T, Yamaguchi Y, Kobayashi T, Serizawa I. CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells. Clin Immunol, 120:247-59, 2006. (PubMed)

63 Araki-Sasaki K, Tanaka T, Ebisuno Y, Kanda H, Umemoto E, Hayashi K, Miyasaka M. Dynamic expression of chemokines and the infiltration of inflammatory cells in the HSV-infected cornea and its associated tissues. Ocul Immunol Inflamm, 14:257-266, 2006. (PubMed)

62 Umemoto E, #Tanaka T, Kanda H, Jin S, Tohya K, Otani K, Matsutani T, Matsumoto M, Ebisuno Y, Jang MH, Fukuda M, Hirata T, Miyasaka M. (#corresponding author) Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow. J Exp Med, 203:1603-1614, 2006. (PubMed)

61 Sato N, Okochi M, Taniyama Y, Kurinami H, Shimamura M, Takeuchi D, Hamada H, Fukumori A, Kiyosue K, Taguchi T, Tanaka T, Miyasaka M, Takeda M, Ogihara T, Morishita R. Development of new screening system for Alzheimer Disease, in vitro Ab sink assay, to indentify the dissociation of soluble Ab from fibrils. Neurobiol Dis, 22:487-495, 2006 (PubMed)

60 *Jang M, *Sougawa N, Tanaka T, Hirata T, Hiroi T, Tohya K, Guo Z, Umemoto E, Ebisuno Y, Yang B, Seoh J, Lipp M, Kiyono H, Miyasaka M. (*equal contribution) CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol, 176:803-810, 2006. (PubMed) Comments in J.Immunol.

2005
59 Nakai K, #Tanaka T, Murai T, Ohguro N, Tano Y, Miyasaka M. (#corresponding author) Invasive human pancreatic carcinoma cells adhere to endothelial tri-cellular corners and increase endothelial permeability. Cancer Sci, 96:766-773, 2005. (PubMed)

58 *Kanemitsu N, *Ebisuno Y, *#Tanaka T, Otani K, Hayasaka H, Kaisho T, Akira S, Katagiri K, Kinashi T, Fujita N, Tsuruo T, Miyasaka M. (*equal contribution, #corresponding author) CXCL13 is an arrest chemokine for B cells in high endothelial venules. Blood, 106:2613-2618, 2005. (PubMed)

2004
57 *Kanda H, *Tanaka T, Matsumoto M, Umemoto E, Ebisuno Y, Kinoshita M, Noda M, Kannagi R, Hirata T, Murai T. Fukuda M, Miyasaka M. (*equal contribution) Endomucin, a sialomucin expressed in high endothelial venules, supports L-selectin-mediated rolling. Int Immunol. 16:1265-1274, 2004. (PubMed)

2003
56 *Ebisuno Y, *Tanaka T, Kanemitsu N, Kanda H, Yamaguchi K, Kaisho T, Akira S, Miyasaka M. (*equal contribution) Cutting Edge: The B cell chemokine CXCL13/B-lymphocyte chemoattractant is expressed in the high endothelial venules of lymph nodes and Peyer’s patches and affects B cell trafficking across high endothelial venules. J Immunol, 171:1642-1646, 2003. (PubMed)

55 *Kashiwazaki M, *Tanaka T, Kanda H, Ebisuno Y, Izawa D, Fukuma N, Akimitsu N, Sekimizu K, Monden M, Miyasaka M. (*equal contribution) A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind the inflammatory but not lymphoid chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol, 15:1219-1227, 2003. (PubMed)

54 Nagakubo D, Murai T, Tanaka T, Usui T, Matsumoto M, Sekiguchi K, Miyasaka M. A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol, 171:553-561, 2003. (PubMed)

53 Tanaka T, Ebisuno Y, Kanda H, Umemoto E, Nagakubo D, Usui T, Kashiwazaki M, Murai T, Miyasaka M. Expression of chemokines and chemokine binding molecules in high endothelial venules that mediate lymphocyte homing into lymph nodes and Peyer’s patches. Microcirculation Annual, 19:3-6, 2003.

52 Kabashima K, Murata T, Tanaka H, Matsuoka T, Sakata D, Yoshida N, Katagiri K, Kinashi T, Tanaka T, Miyasaka M, Nagai H, Ushikubi F, Narumiya S. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat Immunol, 4:694-701, 2003. (PubMed)

2002
51 Usui T, Murai T, Tanaka T, Yamaguchi K, Nagakubo D, Lee CM, Kiyomi M, Tamura S, Matsuzawa Y, Miyasaka M. Characterization of mac25/angiomodulin (AGM) expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells. Int Immunol, 14:1273-1282, 2002. (PubMed)

50 Takeuchi E, Tanaka T, Umemoto E, Tomita T, Shi K, Takahi K, Suzuki R, Ochi T, Miyasaka M. VLA-4-dependent and –independent pathways in cell contact-induced proinflammatory cytokine production by synovial nurse-like cells from rheumatoid arthritis patients. Arthritis Res, 4:R10, 2002. (PubMed)

49 Lee CM, Tanaka T, Murai T, Kondo M, Kimura J, Su W, Kitagawa T, Ito T, Matsuda H, Miyasaka M. Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Res, 62:4282-4288, 2002. (PubMed)

48 Nishioka E, Tanaka T, Yoshida H, Matsumura K, Nishikawa S, Naito A, Inoue J, Funasaka Y, Ichihashi M, Miyasaka M, Nishikawa S. Mucosal addressin cell adhesion molecule1plays an unexpected role in the development of mouse gaurd hair. J Invest Dermatol, 119:632-638, 2002. (PubMed)

47 Kimura F, Gotoh M, Tanaka T, Luo Z, Miyazaki J, Monden M, Uede T, Miyasaka M. Effects of locally expressed CTLA4-Ig in a pancreatic beta cell line on the accelerated graft rejection response induced by donor-specific transfusion. Diabetologia, 45:831-840, 2002. (PubMed)

46 Murata S, Tanaka T, Miyasaka M. Lymphocyte binding to MAdCAM-1 via α4ß7 integrin activates a signal transduction pathway involving tyrosine phosphorylation of paxillin and p105Cas-L. Immunol Letters, 81:223-228, 2002. (PubMed)

45 Saito K, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Kawamoto S, Okubo K, Miyasaka M. Gene expression profiling of mucosal addressin cell adhesion molecule-1+ high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker. J Immunol, 168:1050-1059, 2002. (PubMed)

2001
44 Fujimoto T, Kawashima H, Tanaka T, Hirose M, Toyama-Sorimachi N, Matsuzawa Y, Miyasaka M. CD44 binds a chondroitin sulfate proteoglycan, aggrecan. Int Immunol, 13:359-366, 2001. (PubMed)

2000
43 Iizuka T, Tanaka T, Suematsu M, Miura S, Watanabe T, Koike R, Ishimura Y, Ishii H, Miyasaka N, Miyasaka M. Stage-specific expression of mucosal addressin cell adhesion molecule-1 during embryogenesis in rats. J Immunol, 164: 2463-2471, 2000. (PubMed)

42 Luo Z, Gotoh M, Grochowiecki T, Tanaka T, Kimura F, Kawashima H, Yagita H, Okumura K, Miyasaka M. Anergic T cells generated in vitro suppress rejection response to islet allografts. Transplantation, 69:2144-2148, 2000. (PubMed)

1999
41 Izawa D, Tanaka T, Saito K, Ogihara H, Usui T, Kawamoto S, Matsubara K, Okubo K, Miyasaka M. Expression profile of active genes in mouse lymph node high endothelial cells. Int Immunol, 11:1989-1997, Int.Immunol., 11:1989-1997, 1999. (PubMed)

40 Kanoh N, Dai CF, Tanaka T, Izawa D, Li YF, Kawashima H, Miyasaka M. Constitutive expression of GlyCAM-1 core protein in the rat cochlea. Cell Adhes Commun, 7:259-266, 1999. (PubMed)

39 Hiraoka N, Petryniak B, Nakayama J, Tsuboi S, Suzuki M, Yeh JC, Izawa D, Tanaka T, Miyasaka M, Lowe JB, Fukuda M. A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewisx, an L-selectin ligand displayed by CD34. Immunity, 11:79-89, 1999. (PubMed)

38 Ishii E, Yoshida N, Kimura N, Fujimoto J, Mizutani S, Sako M, Hibi S, Nagano M, Yoshida T, Mori T, Kiyokawa N, Mohri S, Tanaka T, Miyazaki S, Hara T. Clonal dissemination of T-lymphocytes in scid mice from familial hemophagocytic lymphohistiocytosis. Med Pediatr Oncol, 32:201-208, 1999. (PubMed)

37 Luo ZJ, Tanaka T, Kimura F, Miyasaka M. Analysis of the mode of action of a novel immunosuppresant FTY720 in mice. Immunopharmacology, 41:199-207, 1999. (PubMed)

36 Goda K, Tanaka T, Monden M, Miyasaka M. Characterization of an apparently conserved epitope in E- and P-selectin identified by dual-specific monoclonal antibodies. Eur J Immunol, 29:1551-1560, 1999. (PubMed)

1998
35 Ohta Y, Gotoh M, Ohzato H, Fukuzaki T, Nishihara M, Dono K, Umeshita K, Sakon M, Yagita H, Okumura K, Tanaka T, Kawashima H, Miyasaka M, Monden M. Direct antigen presentation through binding of donor ICAM-1 to recipient LFA-1 molecules in xenograft rejection. Transplantation65:1094-1100, 1998. (PubMed)
 
1997
34 Aoki J, Koike S, Asou H, Ise I, Suwa H, Tanaka T, Miyasaka M, Nomoto A. Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp Cell Res, 235:374-384, 1997. (PubMed)

33 Isobe M, Suzuki J, Okubo Y, Horie S, Tanaka T, Miyasaka M, Sekiguchi M. Treatment of murine cardiac allograft by monoclonal antibodies to IL-2 receptor α chain and ß chain. Transplantat Proc, 29: 2301-2302, 1997. (PubMed)

32 Koyanagi Y, Tanaka Y, Kira J, Ito M, Hioki K, Misawa N, Kawano Y, Yamasakai K, Tanaka R, Suzuki Y, Ueyama Y, Terada E, Tanaka T, Miyasaka M, Kobayashi T, Kumazawa Y, Yamamoto N. Primary human immuno-dificiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodificient mouse strain. J Virol, 71:2417-2424, 1997. (PubMed)

1996
31 Miyakawa Y, Fukuchi Y, Ito M, Kobayashi K, Kuramochi T, Ikeda Y, Takebe Y, Tanaka T, Miyasaka M, Nakahata T, Tamaoki N, Nomura T, Ueyama Y, Shimamura K. Establishment of human granulocyte-macrophage colony stimulating factor producing transgenic SCID mice. Br J Haematol, 95:437-442, 1996. (PubMed)

30 Ehl S, Nuesch R, Tanaka T, Miyasaka M, Hengartner H, Zinkernagel, R. A comparison of efficacy and specificity of three NK depleteing antibodies. J Immunol Methods, 199:149-153, 1996. (PubMed)

29 Yano S, Nishioka Y, Izumi K, Tsuruo T, Tanaka T, Miyasaka M, Sone S. Novel metastatic model of human lung cancer in NK-cell depleted SCID mice. Int J Cancer, 67:211-217, 1996. (PubMed)

28 Chastagner P, Moreau JL, Jacques Y, Tanaka T, Miyasaka M, Kondo M, Sugamura K. Theze J. Lack of intermediate-affinity interleukin-2 receptor in mice leads to dependence on interleukin-2 receptor alpha, beta, gamma chain expression for T cell growth. Eur J Immunol, 26:201-206, 1996. (PubMed)

1995
27 Moreau JL, Chastagner P, Tanaka T, Miyasaka M, Kondo M, Sugamura K, Theze J. Control of the IL-2 responsiveness of B lymphocytes by IL-2 and IL-4. J Immunol, 155:3401-3408, 1995. (PubMed)

26 Suwa H., Tanaka T, Kitamura F, Shiohara T, Kuida K, Miyasaka M. Dysregulated expression of the IL-2 receptor ß-chain abrogates development of NK cells and Thy-1+ dendritic epidermal cells in transgenic mice. Int Immunol, 7:1441-1449, 1995. (PubMed)

25 Nakanishi K, Yoshimoto T, Chu CC, Matsumoto H, Hase K, Nagai N, Tanaka T, Miyasaka M, Paul WE, Shinka S. IL-2 inhibits IL-4-dependent IgE and IgG1 production in vitro and in vivo. Int Immunol, 7:259-268, 1995. (PubMed)

1994
24 Tomida S, Hasegawa T, Takeuchi M, Niimi N, Ueda M, Kaneda T, Tanaka T, Tamatani T, Miyasaka M, Yoshikai Y. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 are involved in protection mediated by CD3+TCR alpha beta- T cells at the early stage after infection with Listeria monocytogenes in rats. Int Immunol, 6:955-961, 1994. (PubMed)

23 Ohtsuka K, Iiai T, Watanabe H, Tanaka T, Miyasaka M, Sato K, Asakura H, Abo T. Similarities and differences between extrathymic T cells residing in mouse liver and intestine. Cell Immunol, 153:52-66, 1994. (PubMed)

1993
22 Tanaka T, Kitamura F, Nagasaka Y, Kuida K, Suwa H, Miyasaka M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor ß chain monoclonal antibody in mice. J Exp Med, 178:1103-1107, 1993. (PubMed)

21 Ohmori K, Iiai T, Watanebe H, Tanaka T, Miyasaka M, Abo T. Activation of extrathymic T cells in the liver of mice bearing syngeneic tumors. Biomed Res, 14:65-79, 1993. (PubMed)

20 Kondo A, Imada K, Hattori T, Yamabe H, Tanaka T, Miyasaka M, Okuma M, Uchiyama T. A model of in vivo cell proliferation of adult T cell leukemia. Blood, 82:2501-2509, 1993. (PubMed)

19 Watanabe H, Iiai T, Kimura M, Ohtsuka K, Tanaka T, Miyasaka M, Tsuchida M, Hanawa H, Abo T. Characterization of intermediate TCR cells in the liver of mice with respect to their unique IL-2R expression. Cell Immunol, 149:331-342, 1993. (PubMed)

18 Tanaka T, Nagasaka Y, Kitamura F, Kuida K, Suwa H, Miyasaka M. The role of the interleukin-2 (IL-2)/IL-2 receptor pathway in MRL/lpr lymphoadenopathy: the expanded CD4-8- T cell subset completely lacks functional IL-2 receptors. Eur J Immunol, 23:1378-1380, 1993. (PubMed)

1992
17 Hasegawa T, Tanaka T, Yoshikai Y. The appearance and role of gamma delta T cells in the peritoneal cavity and liver during primary infection with Listeria monocytogenes in rats. Int Immunol, 4:1129-1136, 1992. (PubMed)

16 Kuida K, Tanaka T, Kitamura F, Toyama-Sorimachi N, Miyasaka M. Reconstitution of the intermediate-affinity interleukin-2 receptor by cell fusion. Int Immunol, 4:1123-1128, 1992. (PubMed)

15 Takeuchi Y, Tanaka T, Hamamura K, Sugimoto T, Miyasaka M, Yagita H, Okumura, K. Expression and role of interleukin-2 receptor beta chain on CD4-8- T cell receptor alpha beta+ cells. Eur J Immunol, 22:2929-2935, 1992. (PubMed)

14 Tanaka T, Takeuchi Y, Shiohara T, Kitamura F, Nagasaka Y, Hamamura K, Yagita H, Miyasaka M. In utero treatment with monoclonal antibody to IL-2 receptor beta-chain completely abrogates development of Thy-1+ dendritic epidermal cells. Int Immunol, 4:487-491, 1992. (PubMed)

13 Takahashi K, Nakata M, Tanaka, T, Adachi H, Nakauchi H, Yagita H, Okumura K. CD4 and CD8 regulate interleukin 2 responses of T cells. Proc Natl Acad Sci USA, 89:5557-5561, 1992. (PubMed)

12 Nakanishi K, Hirose S, Yoshimoto T, Ishizashi H, Hiroishi K, Tanaka T, Kono T, Miyasaka M, Taniguchi T, Higashino K. Role and regulation of interleukin (IL)-2 receptor alpha and beta chains in IL-2-driven B cell growth. Proc Natl Acad Sci USA, 89:3551-3555, 1992. (PubMed)

11 Takimoto H, Nakamura T, Takeuchi M, Sumi Y, Tanaka T, Nomoto K, Yoshikai Y. Age-associated increase in number of CD4+CD8+ intestinal intraepithelial lymphocytes in rats. Eur J Immunol, 22:159-164, 1992. (PubMed)

10 Shimada S, Shibagaki N, Tanaka T, Kubota Y, Hashimoto Y, Tamaki K. Identification of an equivalent to murine Thy-1+ dendritic epidermal cells in the rat epidermis. J Dermatol Sci, 3:68-71, 1992. (PubMed)

1991
9 Tanaka T, Tsudo M, Karasuyama H, Kitamura F, Kono T, Hatakeyama M, Taniguchi T, Miyasaka M. A novel monoclonal antibody against murine IL-2 receptor beta-chain: Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol, 147:2222-2228, 1991. (PubMed)

8 Tanaka T, Tsudo M, Karasuyama H, Toyama N, Hatakeyama M, Taniguchi T, Miyasaka M. Signal transduction through the human IL-2 receptor beta-chain expressed in IL-6-dependent mouse B cell hybridoma. Int Immunol, 3:105-108, 1991. (PubMed)

7 Tamatani T, Kotani M, Tanaka T, Miyasaka M. Molecular mechanisms underlying lymphocyte recirculation. II. Differential regulation of LFA-1 in the interaction between lymphocytes and high endothelial cells. Eur J Immunol21:855-858, 1991. (PubMed)

1990
6 Grace JA, Sarawar SR, Bolton EM, Bradley JA, Tanaka T, Bell EB. Renal allograft rejection in CD4+ T cell-reconstituted athymic nude rats. Transplantation, 50:996-1000, 1990. (PubMed)

5 Tsudo M, Karasuyama H, Kitamura F, Tanaka T, Kubo S, Yamamura Y, Tamatani T, Hatakeyama M, Taniguchi , Miyasaka M. The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms. J Immunol, 145:599-606, 1990. (PubMed)

1989
4 Tsudo, M., Karasuyama, H., Kitamura, F., Nagasaka, Y., Tanaka, T. & Miyasaka, M. Reconstitution of a functional IL-2 receptor by the ß-chain cDNA. A newly acquired receptor transduces negative signal. J.Immunol., 143:4039-4043, 1989. (PubMed)

3 Tanaka T, Suzuki S, Masuko, Hashimoto Y. In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen. Jpn J Cancer Res, 80:380-386, 1989. (PubMed)

2 Tanaka T, Masuko T, Yagita H, Tamura T, Hashimoto Y. Characterization of a CD3-like rat T cell surface antigen recognized by a monoclonal antibody. J Immunol, 142:2791-2795, 1989. (PubMed)

1988
1 Tanaka T, Masuko T, Hashimoto Y. Appearance of a proliferation-associated antigen, gp125, on rat and human lymphocytes by co-stimulation with phorbol ester and calcium ionophore. J Biochem, 103:644-649, 1988. (PubMed)